Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis

OBJECTIVE: Despite the development of new biologic therapies, methotrexate (MTX) remains the preferred initial disease-modifying anti-rheumatic drug to treat rheumatoid arthritis (RA). Adherence to disease-modifying anti-rheumatic drugs is suspected to be highly variable potentially leading to reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Nebesky, Jan Michael, de Bock, Elodie, de la Loge, Christine, Arnould, Benoit, Davey, Robert, Devenport, Jenny, Pethö-Schramm, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353039/
https://www.ncbi.nlm.nih.gov/pubmed/34373947
http://dx.doi.org/10.1186/s41687-021-00339-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353039/
https://www.ncbi.nlm.nih.gov/pubmed/34373947
http://dx.doi.org/10.1186/s41687-021-00339-5

Ejemplares similares